June 17, 2020 / 10:37 AM / 22 days ago

Coronavirus vaccine could be on market in mid-2021: CureVac

FILE PHOTO: An employee of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020. Picture taken on March 12, 2020. REUTERS/Andreas Gebert/File Photo

BERLIN (Reuters) - A vaccine against the coronavirus pandemic by CureVac could be on the market in mid-2021, the unlisted German company said on Wednesday.

CureVac might be able to apply for approval early next year, Klaus Cichutek, President of German vaccine regulator PEI, added during a joint videoconference.

Reporting by Ludwig Burger and Thomas Seythal; Editing by Madeline Chambers

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below